ALT
Altimmune Inc
3.20$
-6.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -9.6% | +1,031.5% | -72.0% | -13.1% | -1.3% | +353.4% | -10.7% | -5.5% | +1.8% | -33.9% | +100.9% | |
| – | -10.5% | +1,190.3% | -89.4% | +67.8% | +0.1% | +484.5% | -11.3% | -5.5% | +8.7% | -34.5% | +102.7% | |
| – | -16.5% | +889.1% | -94.3% | +284.5% | -73.4% | +1,193.3% | +64.2% | -41.6% | +21.6% | -72.7% | +18.5% | |
| – | -16.5% | +1,318.2% | -96.0% | +284.5% | +10.4% | +479.8% | -11.9% | -2.8% | +7.0% | -33.3% | +107.3% | |
| – | +261.5% | -32.3% | +917.7% | -56.0% | -63.1% | +649.8% | -52.8% | -56.5% | +91.0% | -35.8% | -44.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -28.3% | -48.2% | +398.7% | +122.6% | -17.8% | -4.3% | +37.0% | +15.8% | – | – | – | |
| – | +857.9% | -89.6% | -100.0% | – | – | – | – | – | – | – | – | |
| – | +4,044.5% | -16.1% | +158.9% | -64.2% | -8.1% | +0.7% | -3.2% | +0.0% | – | – | – | |
| – | -13.3% | +6,288.5% | -93.0% | -55.1% | +32.6% | +125.3% | +2.6% | +9.7% | -23.5% | -4.5% | +248.4% | |
| – | -15.6% | +9,298.6% | -98.1% | +17.9% | -13.3% | +206.4% | +52.0% | -6.7% | -28.8% | -13.8% | +43.3% | |
| – | -97.8% | +8,828.6% | -96.6% | +44.1% | +262.4% | +37.5% | +15.3% | +9.9% | +9.7% | -43.8% | -8.2% | |
| – | +33.1% | +77.8% | -86.1% | +188.9% | -95.1% | +3,258.3% | +232.3% | +136.1% | -56.9% | -89.8% | +1,187.7% | |
| – | – | -3.5% | +769.8% | -59.5% | +0.7% | -2.0% | -20.5% | – | – | – | – | |
| – | -8.9% | +16.9% | +150.2% | -0.7% | -5.8% | +396.2% | -11.8% | -7.0% | +4.8% | -36.4% | +82.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +11.2% | +8.0% | +85.3% | +556.6% | +368.3% | +95.3% | +61.0% | +13.7% | +13.5% | +33.3% | +24.1% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.